⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 1, 2024Journal of Thoracic DiseaseOpen Access

Characteristics and outcomes of salvage surgery after immune checkpoint inhibitor therapy for initially unresectable non-small cell lung cancer

Masatsugu Hamaji Hiroaki Ozasa Yuichi Sakamori Kazuhiro Terada Akihiko Yoshizawa Ryutaro Kikuchi Yasuto Sakaguchi Makoto Sonobe Yusuke Muranishi Ryo Miyahara Hideki Motoyama Mitsugu Omasa Hiroshi Date

View Full Paper

Ask AI

Bookmark

Share

Abstract

Immune checkpoint inhibitors (ICIs) improved the long-term survival outcomes in patients with advanced non-small cell lung cancer (NSCLC), whereas the role of salvage surgery after ICIs was unknown. The object of this study was to investigate characteristics and outcomes of patients who underwent salvage surgery after ICIs.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hamaji et al. (2024) studied this question.

synapsesocial.com/papers/68e59c66b6db6435875373ee https://doi.org/10.21037/jtd-24-891

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Safety and Efficacy of Salvage Surgery after Treatment With Immune‐Checkpoint Adjuvant Inhibitors for Advanced Non‐Small Cell Lung Cancer: A Multicentric Study2024 · 8 citations
2Salvage lung resection after immunotherapy is feasible and safe2024 · 8 citations
3Long-term Outcomes of Salvage Surgery<i>Versus</i>Induction Therapy Followed by Surgical Resection for Advanced NSCLC: A Propensity Score-matched Analysis2024 · 1 citations
4The Utility of Immune Checkpoint Inhibition in the Management of Resectable Non-Small Cell Lung Cancer2025 · 1 citations
5A Real‐World Study of Resectable <scp>NSCLC</scp> Following Neoadjuvant Immunotherapy: Should Postoperative Adjuvant Immunotherapy be Recommended?2025 · 4 citations

More related papers

The Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer2026
Current Roles of Neoadjuvant and Perioperative Immunotherapy in Non–Small Cell Lung Cancer2026
The real-world treatment characteristic and efficacy of immune checkpoint inhibitors in non-small cell lung cancer: Data from a retrospective cohort study2024

More from Journal of Thoracic Disease

Landiolol for preventing postoperative atrial fibrillation: lessons from Japan for all?Tue,
Seven years of PARTNER 3: the evolution of a lifetime valve strategy, reassurance and residual uncertaintyTue,